Siriwardana, P. N.; Deen, K. I.
April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA17
Academic Journal
This study evaluated the completeness of pathology reports in 82 consecutive patients based on the Minimum Data Set by the Royal College of Pathologists, Great Britain. The quality of a histopathology report in CRC will determine prognosis and the need for adjuvant therapy. The pathology reports were reviewed by a single person who looked for 17 pathology data sets for colon cancer and 15 for rectal cancer. Completeness of reporting was classified as 40-50%, 60-70% or 80-100%. Tumour involvement at resection margin was reported in 91 .5%.


Related Articles

  • Computed Virtual Chromoendoscopy for Classification of Small Colorectal Lesions: A Prospective Comparative Study. Pohl, Juergen; Nguyen-Tat, Marc; Pech, Oliver; May, Andrea; Rabenstein, Thomas; Ell, Christian // American Journal of Gastroenterology;Mar2008, Vol. 103 Issue 3, p562 

    OBJECTIVES: Standard colonoscopy offers no reliable discrimination between neoplastic and nonneoplastic colorectal lesions. Computed virtual chromoendoscopy with the Fujinon intelligent color enhancement (FICE) system is a new dyeless imaging technique that enhances mucosal and vascular...

  • Association of Time to Recurrence With Thymidylate Synthase and Dihydropyrimidine Dehydrogenase mRNA Expression in Stage II and III Colorectal Cancer Kornmann, Marko; Link, Karl H.; Galuba, Inga; Ott, Kati; Schwabe, Wolfgang; Häusler, Peter; Scholz, Peter; Sträter, Jörn; Polat, Sucan; Leibl, Bernhard; Kettner, Erika; Schlichting, Christoph; Baumann, Wolfram; Schramm, Harald; Hecker, Ute; Ridwelski, Karsten; Vogt, Jürgen H.; Zerbian, Klaus-Ullrich; Schütze, Frank; Kreuser, Ernst D. // Journal of Gastrointestinal Surgery;May2002, Vol. 6 Issue 3, p331 

    Patients with International Union Against Cancer (UICC) stage IIb and III colon cancer and stage II and III rectal cancer may receive adjuvant chemotherapy with 5-fluorouracil (5-FU). High levels of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) have been associated with...

  • Impact of Neoadjuvant Therapy on Postoperative Complications in Patients Undergoing Resection for Rectal Adenocarcinoma. Turner, Immanuel I.; Russell, Gregory B.; Blackstock, A. William; Levine, Edward A. // American Surgeon;Dec2004, Vol. 70 Issue 12, p1045 

    Surgical resection continues to be the mainstay of treatment for rectal cancer. Neoadjuvant therapy (chemotherapy and radiation) has also been shown to be efficacious. The impact of preoperative chemotherapy and radiation on postoperative complications is unclear. The purpose of this study is to...

  • Marges d’exérèse et qualité de prise en charge des cancers du rectum. Le Tinier, F.; Jafari, M.; Mirabel, X.; Vanseymortier, L. // Oncologie;Jan2010, Vol. 12 Issue 1, p34 

    La prise en charge du cancer du rectum s’est considérablement améliorée ces derniéres années avec l’émergence de nouvelles techniques chirurgicales et la place croissante des traitements néoadjuvants. De plus, de nouveaux facteurs pronostiques comme la marge...

  • Issues remain for treating colorectal cancer. Reynolds, Tom // JNCI: Journal of the National Cancer Institute;4/5/95, Vol. 87 Issue 7, p480 

    Presents an overview of the studies on the adjuvant treatment of colorectal cancer. Studies of the combination of fluorouracil and leucovorin; Effect of 17-1A monoclonal antibodies on colon cancer; Administration route of fluorouracil; Intraportal chemotherapy; Therapeutic uses of interferon...

  • Dutch trial casts doubt on colorectal adjuvant therapy. Reynolds, Tom // JNCI: Journal of the National Cancer Institute;4/5/95, Vol. 87 Issue 7, p476 

    Reports that the results of a study conducted in the Netherlands casts doubt on the benefits of adjuvant therapy for colorectal cancer. Design of the clinical trial, as reported by Frans A.N. Zoetmulder; Extension of cancer patients' lives as a result of adjuvant therapy; Pharmacology of the...

  • Colon cancer: ESMO Clinical Recommendations for diagnosis, adjuvant treatment and follow-up. Van Cutsem, E. J. D. // Annals of Oncology;May2007 Supplement 2, Vol. 18, pii21 

    The article presents the clinical recommendations of the European Society for Medical Oncology (ESMO) for the diagnosis, adjuvant treatment and follow-up of colon cancer. The disease's diagnosis requires histopathologic confirmation. The recommended therapy for stages T1-4 is adjuvant...

  • The impact of surgically induced ischaemia on protein levels in patients undergoing rectal cancer surgery. Atkin, G. K.; Daley, F. M.; Bourne, S.; Glynne-Jones, R.; Northover, J. M. A.; Wilson, G. D. // British Journal of Cancer;10/9/2006, Vol. 95 Issue 7, p928 

    The goal of targeted therapy has driven a search for markers of prognosis and response to adjuvant therapy. The surgical resection of a solid tumour induces tissue ischaemia and acidosis, both potent mediators of gene expression. This study investigated the impact of colorectal cancer (CRC)...

  • Factors affecting management decisions in rectal cancer in clinical practice: results from a national survey. Habr-Gama, A.; Perez, R. O.; São Julião, G. P.; Proscurshim, I.; Nahas, S. C.; Gama-Rodrigues, J. // Techniques in Coloproctology;Mar2011, Vol. 15 Issue 1, p45 

    Background: Management of rectal cancer has become increasingly complex and a multidisciplinary approach is considered of key importance for improving outcomes. A national survey among specialists involved in this multidisciplinary setting was performed. Methods: A web-based survey containing 11...


Read the Article


Sign out of this library

Other Topics